Tissue Sampling Guides for Porcine Biomedical Models

Toxicologic Pathology

Volumn 44, Issue 3, 2016, Pages 414-420

  Albl, Barbara ^a,b   Haesner, Serena ^a   Braun Reichhart, Christina ^a   Streckel, Elisabeth ^a   Renner, Simone ^a   Seeliger, Frank ^c   Wolf, Eckhard ^a,d   Wanke, Rüdiger ^a   Blutke, Andreas ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Minitube GmbH   (Germany)

^c ASTRAZENECA R AND D   (Sweden)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

biobank; biomedical research; minipig; necropsy; organ specimen collection; pig; systematic random sampling

Indexed keywords

DNA; ELECTROLYTE; PARAFFIN; PLASTIC; PROTEIN; RNA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ELECTRON MICROSCOPY; GENE EXPRESSION; HISTOLOGY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METABOLITE; NONHUMAN; PIG; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SAMPLING; STEREOLOGY; TISSUE SAMPLING; ANIMAL; CYTOCHEMISTRY; MEDICAL RESEARCH; PROCEDURES; RANDOMIZATION; SPECIMEN HANDLING;

ANIMALS; BIOMEDICAL RESEARCH; HISTOCYTOCHEMISTRY; MODELS, ANIMAL; RANDOM ALLOCATION; SPECIMEN HANDLING; SWINE;

EID: 84961615940     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623316631023     Document Type: Article

References (34)

1. Abbott A., (2015). Inside the first pig biobank. Nature 519, 397-98.
2. Aigner B., Renner S., Kessler B., Klymiuk N., Kurome M., Wunsch A., Wolf E., (2010). Transgenic pigs as models for translational biomedical research. J Mol Med (Berl) 88, 653-64.
3. Bolon B., Garman R. H., Pardo I. D., Jensen K., Sills R. C., Roulois A., Radovsky A., Bradley A., Andrews-Jones L., Butt M., Gumprecht L., (2013). STP position paper: Recommended practices for sampling and processing the nervous system (brain, spinal cord, nerve, and eye) during nonclinical general toxicity studies. Toxicol Pathol 41, 1028-48.
4. Bregman C. L., Adler R. R., Morton D. G., Regan K. S., Yano B. L., (2003). Recommended tissue list for histopathologic examination in repeat-dose toxicity and carcinogenicity studies: a proposal of the Society of Toxicologic Pathology (STP). Toxicol Pathol 31, 252-53.
5. Goodwin R. J., Pitt A. R., Harrison D., Weidt S. K., Langridge-Smith P. R., Barrett M. P., Logan Mackay C., (2011). Matrix-free mass spectrometric imaging using laser desorption ionisation Fourier transform ion cyclotron resonance mass spectrometry. Rapid Commun Mass Spectrom 25, 969-72.
6. Gun G., Kues W. A., (2014). Current progress of genetically engineered pig models for biomedical research. Biores Open Access 3, 255-64.
7. Gundersen H. J. G., Jensen E. B., (1987). The efficiency of systematic sampling in stereology and its prediction. J Microsc 147, 229-63.
8. Gundersen H. J. G., Mirabile R., Brown D., Boyce R. W., (2013). Stereological principles and sampling procedures for toxicologic pathologists. In Haschek and Rousseaux's Handbook of Toxicologic Pathology (Haschek W., Rousseaux C., Wallig M.,. eds.), 3rd ed., 215-86. London: Academic Press.
9. Haley P., Perry R., Ennulat D., Frame S., Johnson C., Lapointe J. M., Nyska A., Snyder P., Walker D., Walter G., (2005). STP position paper: Best practice guideline for the routine pathology evaluation of the immune system. Toxicol Pathol 33, 404-7,. discussion 408.
10. Hermanns W., Liebig K., Schulz L. C., (1981). Postembedding immunohistochemical demonstration of antigen in experimental polyarthritis using plastic embedded whole joints. Histochemistry 73, 439-46.
11. Howard C. V., Reed M. G., (2005). Unbiased stereology. QTP Publications, Coleraine, UK.
12. Kemter E., Lieke T., Kessler B., Kurome M., Wuensch A., Summerfield A., Ayares D., Nagashima H., Baars W., Schwinzer R., Wolf E., (2012). Human TNF-related apoptosis-inducing ligand-expressing dendritic cells from transgenic pigs attenuate human xenogeneic T cell responses. Xenotransplantation 19, 40-51.
13. Kittel B., Ruehl-Fehlert C., Morawietz G., Klapwijk J., Elwell M. R., Lenz B., O'Sullivan M. G., Roth D. R., Wadsworth P. F., Group R., Group N., (2004). Revised guides for organ sampling and trimming in rats and mice-Part 2. A joint publication of the RITA and NACAD groups. Exp Toxicol Pathol 55, 413-31.
14. Klymiuk N., Aigner B., Brem G., Wolf E., (2010). Genetic modification of pigs as organ donors for xenotransplantation. Mol Reprod Dev 77, 209-21.
15. Klymiuk N., Blutke A., Graf A., Krause S., Burkhardt K., Wuensch A., Krebs S., Kessler B., Zakhartchenko V., Kurome M., Kemter E., Nagashima H., Schoser B., Herbach N., Blum H., Wanke R., Aartsma-Rus A., Thirion C., Lochmuller H., Walter M. C., Wolf E., (2013). Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle. Hum Mol Genet 22, 4368-82.
16. Klymiuk N., Bocker W., Schonitzer V., Bahr A., Radic T., Frohlich T., Wunsch A., Kessler B., Kurome M., Schilling E., Herbach N., Wanke R., Nagashima H., Mutschler W., Arnold G. J., Schwinzer R., Schieker M., Wolf E., (2012a). First inducible transgene expression in porcine large animal models. FASEB J 26, 1086-99.
17. Klymiuk N., Mundhenk L., Kraehe K., Wuensch A., Plog S., Emrich D., Langenmayer M. C., Stehr M., Holzinger A., Kroner C., Richter A., Kessler B., Kurome M., Eddicks M., Nagashima H., Heinritzi K., Gruber A. D., Wolf E., (2012b). Sequential targeting of CFTR by BAC vectors generates a novel pig model of cystic fibrosis. J Mol Med (Berl) 90, 597-608.
18. Klymiuk N., Seeliger F., Bohlooly Y. M., Blutke A., Rudmann D. G., Wolf E, Tailored pig models for preclinical efficacy and safety testing of targeted therapies. Toxicol Pathol. Published electronically October 27, 2015. doi:0192623315609688.
19. Klymiuk N., van Buerck L., Bahr A., Offers M., Kessler B., Wuensch A., Kurome M., Thormann M., Lochner K., Nagashima H., Herbach N., Wanke R., Seissler J., Wolf E., (2012c). Xenografted islet cell clusters from INSLEA29Y transgenic pigs rescue diabetes and prevent immune rejection in humanized mice. Diabetes 61, 1527-32.
20. Kurome M., Kessler B., Wuensch A., Nagashima H., Wolf E., (2015). Nuclear transfer and transgenesis in the pig. Methods Mol Biol 1222, 37-59.
21. Lunney J. K., (2007). Advances in swine biomedical model genomics. Int J Biol Sci 3, 179-84.
22. Morawietz G., Ruehl-Fehlert C., Kittel B., Bube A., Keane K., Halm S., Heuser A., Hellmann J., Group R., Group N., (2004). Revised guides for organ sampling and trimming in rats and mice-Part 3. A joint publication of the RITA and NACAD groups. Exp Toxicol Pathol 55, 433-49.
23. Reagan W. J., Irizarry-Rovira A., Poitout-Belissent F., Bolliger A. P., Ramaiah S. K., Travlos G., Walker D., Bounous D., Walter G., and Bone Marrow Working Group of, A. S. (2011). Best practices for evaluation of bone marrow in nonclinical toxicity studies. Vet Clin Pathol 40, 119-34.
24. Renner S., Braun-Reichhart C., Blutke A., Herbach N., Emrich D., Streckel E., Wunsch A., Kessler B., Kurome M., Bahr A., Klymiuk N., Krebs S., Puk O., Nagashima H., Graw J., Blum H., Wanke R., Wolf E., (2013). Permanent neonatal diabetes in INS(C94Y) transgenic pigs. Diabetes 62, 1505-11.
25. Renner S., Fehlings C., Herbach N., Hofmann A., von Waldthausen D. C., Kessler B., Ulrichs K., Chodnevskaja I., Moskalenko V., Amselgruber W., Goke B., Pfeifer A., Wanke R., Wolf E., (2010). Glucose intolerance and reduced proliferation of pancreatic beta-cells in transgenic pigs with impaired glucose-dependent insulinotropic polypeptide function. Diabetes 59, 1228-38.
26. Renner S., Romisch-Margl W., Prehn C., Krebs S., Adamski J., Goke B., Blum H., Suhre K., Roscher A. A., Wolf E., (2012). Changing metabolic signatures of amino acids and lipids during the prediabetic period in a pig model with impaired incretin function and reduced beta-cell mass. Diabetes 61, 2166-75.
27. Ruehl-Fehlert C., Kittel B., Morawietz G., Deslex P., Keenan C., Mahrt C. R., Nolte T., Robinson M., Stuart B. P., Deschl U., Group R., Group N., (2003). Revised guides for organ sampling and trimming in rats and mice-Part 1. Exp Toxicol Pathol 55, 91-106.
28. Scherle W., (1970). A simple method for volumetry of organs in quantitative stereology. Mikroskopie 26, 57-60.
29. Streckel E., Braun-Reichhart C., Herbach N., Dahlhoff M., Kessler B., Blutke A., Bahr A., Ubel N., Eddicks M., Ritzmann M., Krebs S., Goke B., Blum H., Wanke R., Wolf E., Renner S., (2015). Effects of the glucagon-like peptide-1 receptor agonist liraglutide in juvenile transgenic pigs modeling a pre-diabetic condition. J Transl Med 13, 73.
30. Tornqvist E., Annas A., Granath B., Jalkesten E., Cotgreave I., Oberg M., (2014). Strategic focus on 3R principles reveals major reductions in the use of animals in pharmaceutical toxicity testing. PLoS One 9, e101638.
31. Redbook. (2000). IV.B.1 General Guidelines for Designing and Conducting Toxicity Studies. U.S. Food and Drug Administration. Last modified November 2003. http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/IngredientsAdditivesGRASPackaging/ucm078315.htm.
32. Wolf E., Braun-Reichhart C., Streckel E., Renner S., (2014). Genetically engineered pig models for diabetes research. Transgenic Res 23, 27-38.
33. Wu Z., Xu Z., Zou X., Zeng F., Shi J., Liu D., Urschitz J., Moisyadi S., Li Z., (2013). Pig transgenesis by piggyBac transposition in combination with somatic cell nuclear transfer. Transgenic Res 22, 1107-18.
34. Wuensch A., Baehr A., Bongoni A. K., Kemter E., Blutke A., Baars W., Haertle S., Zakhartchenko V., Kurome M., Kessler B., Faber C., Abicht J. M., Reichart B., Wanke R., Schwinzer R., Nagashima H., Rieben R., Ayares D., Wolf E., Klymiuk N., (2014). Regulatory sequences of the porcine THBD gene facilitate endothelial-specific expression of bioactive human thrombomodulin in single- and multitransgenic pigs. Transplantation 97, 138-47.